Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review.
Duda-Chodak A, Tarko T, Satora P, Sroka P. · 2015
Read Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review. by Duda-Chodak A, Tarko T, Satora P, Sroka P. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4365176.txt.
Introduction
Aleksandra Duda-Chodak, Tomasz Tarko, Paweł Satora, and Paweł Sroka reviewed how food compounds meet gut microbes, in the European Journal of Nutrition in 2015. The gut microbiome changes many food chemicals in ways human enzymes cannot, since bacterial work in the gut runs without oxygen. Their review centers on polyphenols, plant compounds whose health effects depend heavily on what gut bacteria make of them.
Bacterial change usually lowers a compound's activity, but at times it creates a product with stronger effects. The review maps the paths polyphenols take through gut bacteria and the active products that result. It also covers how diet and age reshape the gut community, and why balance between the immune system and gut microbes matters for health. The message is that food effects cannot be judged apart from the microbes that process them.
Catalog record
| CREATOR | Duda-Chodak A, Tarko T, Satora P, Sroka P. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review By Aleksandra Duda-Chodak, Tomasz Tarko, Paweł Satora, Paweł Sroka Published in: European Journal of Nutrition DOI: 10.1007/s00394-015-0852-y ABSTRACT The intestinal microbiome plays an important role in the metabolism of chemical compounds found within food. Bacterial metabolites are different from those that can be generated by human enzymes because bacterial processes occur under anaerobic conditions and are based mainly on reactions of reduction and/or hydrolysis. In most cases, bacterial metabolism reduces the activity of dietary compounds; however, sometimes a specific product of bacterial transformation exhibits enhanced properties. Studies on the metabolism of polyphenols by the intestinal microbiota are crucial for understanding the role of these compounds and their impact on our health. This review article presents possible pathways of polyphenol metabolism by intestinal bacteria and describes the diet-derived bioactive metabolites produced by gut microbiota, with a particular emphasis on polyphenols and their potential impact on human health. Because the etiology of many diseases is largely correlated with the intestinal microbiome, a balance between the host immune system and the commensal gut microbiota is crucial for maintaining health. Diet-related and age-related changes in the human intestinal microbiome and their consequences are summarized in the paper. INTRODUCTION For many years, it was thought that the function of the large intestine was to reabsorb water and salt and remove unused food debris. It is now evident that the intestinal microbiota plays an important, if not crucial, role in the metabolism of chemical compounds found within foods. The large number of bacteria inhabiting the large intestine forms a highly complex ecosystem called the ‘intestinal microbiome’. The word ‘microbiome’ was first introduced in 2001 to define the collective genomes of the microbiota [1]. In 2007, the ‘human microbiome project’ was launched with the aim of collecting and integrating genomic information from many diverse human microbiomes and examining the relationship between changes in the human microbiome and various diseases [2, 3]. Growing scientific interest in the composition of the microbiome and its impact on human health has led to the initiation of many similar projects all over the world. The NIH Human Microbiome Project (2007, USA) aimed to characterize the influence of the microbiota on the human body and to correlate changes in these microbial populations with human health. The Irish ELDERMET Project (2007–2013) focused on characterization of the fecal microbiota associated with aging and aimed to correlate the composition, diversity and metabolic potential of the fecal microbial metagenome with health, diet and lifestyle. MetaHIT (metagenomics of the human intestinal tract, 2008–2011) was a European project focused on assessing the role of the microbiota in inflammatory bowel disease and obesity. The French project Microbes (human intestinal microbiome in obesity and nutritional transition, 2008–2010) sought to identify metagenomic signatures that characterize the relationship between the intestinal microbiome and the nutritional and metabolic status of the host. The interactions between intestinal microbes and host health were also evaluated by the Australian jumpstart human microbiome project (2009) and Canadian Human Microbiome Initiative (2009). Still in progress is the Korean Microbiome Diversity using Korean Twin Cohort Project (2010–2015) that aims to determine the microbiomes on various epithelial sites of the human body using the Korean twin cohort and to investigate the relationship between the human microbiome and disease. The aim of this article is to review recent studies on factors affecting the composition of the human gut microbiota with a particular emphasis on polyphenolic compounds. The manuscript presents a compilation of the knowledge on functional aspects of the normal gut microbiota from two perspectives: (1) the role of particular microbial species in the metabolism of polyphenols and (2) a detailed insight into the role of biotransformation of polyphenols in relation to their beneficial functions on health. MICROBIAL DIVERSITY OF THE HUMAN GUT MICROBIOTA The human gut is colonized by an enormous number of microorganisms, mainly bacteria. It is estimated that the microbiota of a human adult is composed of ~1014 bacterial cells, which is ten times more than the total number of human cells [4]. The metabolic capacity of the intestinal microbiome is approximately 100-fold greater than that of the human liver. This is a result of the great diversity of bacterial species forming the population, and hence the large number of genes which they contain [4]. The process of gut colonization starts immediately after birth. The infant’s microbiota initially shows instability and low diversity, evolving into a more stable adult-type microbiota after the first 2–4 years of life. Its final composition depends on environmental factors. According to Sakata et al. [5] in the first week of human life enterobacteria, streptococci, enterococci and staphylococci are already present in the infant’s gut while anaerobes such as bifidobacteria, lactobacilli and Bacteroides spp. are not. The gradual consumption of oxygen in the intestine by aerobic microorganisms provides conditions for the settlement of anaerobic bacteria. Breastfeeding is a significant factor in the determination of the neonatal gut microbiota. In full-time breastfed babies (1 month old), bifidobacteria constituted a predominant group in the feces, while in formula-fed infants, although bifidobacteria were also the predominant species, other bacteria such as enterobacteria, enterococci, lactobacilli, clostridia and Bacteroides spp. were present in significantly higher numbers compared with breastfed infants [6, 7]. Initial colonization of the intestine does not appear to be random but rather ‘pre-programmed’. Although host genetics can predict microbial composition to an extent, several extrinsic factors (mode of infant delivery, antibiotic exposure, neonatal nutrition, adult nutrition, stress, age, degree of hygiene, bacterial infections) contribute to the development of an individual’s unique microbial composition and as a result, susceptibility to several diseases [8, 9]. It has been shown that infants born vaginally acquire their own mother’s vaginal and intestinal flora (dominated by Lactobacillus, Prevotella, Atopobium or Sneathia spp.) and have higher levels of Clostridium spp, while infants delivered by cesarean section have increased levels of skin-associated bacteria including Staphylococcus, Corynebacterium and Propionibacterium spp. [7, 10, 11]. The microbiota of the human gastrointestinal tract starts in the mouth, and the number of viable cells is estimated at 108–1010 colony-forming units (CFU) of bacteria per gram of saliva. As a result of the swallowing reflex, these bacteria are continuously transferred to the subsequent parts of the gastrointestinal tract. The number of microorganisms is significantly reduced in the stomach (~103 CFU/g gastric juice), duodenum and jejunum (102–104 CFU/g content), increasing again in the ileum and colon (approximately 1010 CFU/g content and 1010–1012 CFU/g content, respectively) [12]. The enormous number of microorganisms that inhabit the human large intestine (up to 1012 bacteria per gram of colonic content) is the highest accumulation of microorganisms in the environment that has been reported to date [13]. The composition, as well as the ratio of different species that form the intestinal microbiome, is very diverse within the human population [14]. The composition of the human gut ecosystem is influenced by multiple and diverse factors, such as age, origin, environment, dietary habits (including probiotics) and the application of antibiotics. Hence, each individual has his or her own unique profile of microbial species, which can be compared to a fingerprint. Owing to the multitude of direct and indirect interactions with the host organism, the intestinal microbiome